Td Asset Management Inc Recursion Pharmaceuticals, Inc. Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022
SELL
$5.04 - $9.26 $163,971 - $301,264
-32,534 Closed
0 $0
Q1 2022

May 10, 2022
SELL
$6.16 - $18.03 $116,424 - $340,767
-18,900 Reduced 36.75%
32,534 $233,000
Q4 2021

Feb 10, 2022
BUY
$16.14 - $21.86 $174,312 - $236,088
10,800 Added 26.58%
51,434 $881,000
Q2 2021

Aug 11, 2021
BUY
$18.0 - $37.42 $731,412 - $1.52 Million
40,634 New
40,634 $1.23 Million

Others Institutions Holding RXRX

# of Institutions
299
Shares Held
241M
Call Options Held
1.35M
Put Options Held
2.32M
View Full List

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.31B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email